Overview
Today’s market environment presents a Cautious regime with a total of 18 Continuation Breakout signals detected. While the signal count is robust, the broader market sentiment is Very Bearish / Bearish, with only 48.2% of stocks trading above their 40-day Simple Moving Average. This divergence suggests that while individual stocks are showing relative strength, the macro headwinds are significant.
Quality Score: 2.5/5
Given the Cautious regime, we apply a strict filter: only the highest-conviction setups with strong institutional backing and clear demand zones score above a 3. The market breadth is weak, meaning “breakouts” that lack volume confirmation or sector support are likely to fail. We are seeing a heavy concentration in the Medical/Pharmaceutical sector (LLY, MGNX, INSM, IDXX, AMGN), indicating a defensive rotation or specific sector momentum rather than broad-based market strength.
Top performing sectors by volatility include Technology and Real Estate, while Materials and Utilities are lagging. Traders should be selective, focusing on stocks with high institutional ownership (Bucket B1/B2) and those testing key demand zones with supportive volume profiles.
Top 5 Picks
LLY ($1078.78) — Medical / Pharmaceuticals
Technical Setup: Eli Lilly stands out as the highest-conviction play in a defensive sector. Trading near its 52-week high (only -6.1% away), LLY is currently testing a critical at_demand zone with a strength rating of 5.4 on the 30-minute timeframe. Although RVOL is moderate at 0.8, the price action is holding firm above the demand boundary ($1068.85). The stock is in Bucket B1/B2, indicating strong institutional accumulation. With a 30m demand zone strength of 5.4 and supply located 4.5% higher, the risk/reward ratio favors a continuation move if the $1065 support holds.
Key Levels:
| Level Type | Price | Notes |
|---|---|---|
| Entry | $1070.00 – $1079.00 | Buy on confirmation above intraday pivot |
| Stop Loss | $1064.00 | Below 30m demand lower bound ($1065) |
| Target 1 | $1115.00 | Approaching 52W High resistance |
| Target 2 | $1133.00 | 30m Supply Zone Upper Bound |
Institutional Backing: Held by 6,392 funds (Bucket B1, B2).
CF ($116.60) — Agriculture / Chemicals
Technical Setup: CF is exhibiting a powerful weekly demand setup. The stock is currently at a at_demand zone with an exceptional strength rating of 8 on the weekly timeframe. Despite the bearish market sentiment, CF has rallied 2.8% today. The weekly demand zone ($100.41 – $115.78) provides a massive safety net, with the current price sitting just above the upper edge of this zone. Institutional ownership is high (1,941 funds, Bucket B2). The setup offers a wide stop distance but a significant upside potential if the weekly demand holds firm.
Key Levels:
| Level Type | Price | Notes |
|---|---|---|
| Entry | $116.00 – $117.50 | Breakout above 1h supply test |
| Stop Loss | $114.50 | Below 1h support and weekly demand edge |
| Target 1 | $121.00 | 1h Supply Zone Lower Bound |
| Target 2 | $125.00 | Psychological Resistance |
Institutional Backing: Held by 1,941 funds (Bucket B2).
AMGN ($338.22) — Medical / Profitable Biotech
Technical Setup: Amgen is showing relative strength with a 3.0% gain and is positioned at a at_demand zone. The weekly demand zone ($319.78 – $330.41) is strong (Strength 5.9), and the stock is currently trading just above it. Notably, there is a tight 4-hour supply zone immediately above ($339.52 – $341.01) with a strength of 6.2. This creates a “squeeze” setup where a breakout above $341 could trigger a rapid move. With 3,822 institutional funds and Bucket N/A (highly liquid), AMGN offers a high-probability continuation play if it clears the immediate supply overhead.
Key Levels:
| Level Type | Price | Notes |
|---|---|---|
| Entry | $338.50 – $341.50 | Wait for breakout above 4h supply |
| Stop Loss | $329.00 | Below weekly demand upper bound |
| Target 1 | $355.00 | Previous consolidation high |
| Target 2 | $370.00 | Next major resistance |
Institutional Backing: Held by 3,822 funds.
EXPE ($225.41) — Leisure / Travel Booking
Technical Setup: Expedia is a contrarian play in the Leisure sector, testing a massive monthly demand zone ($209.80 – $220.00) with a strength rating of 7. Despite a slight -0.4% change today, the stock is holding above the critical monthly support level. The risk is low (22.4% ATR) relative to the potential upside if the monthly demand holds. With 2,445 institutional funds, this is a high-conviction bounce play. The setup is valid as long as the price remains above the $220 psychological support level.
Key Levels:
| Level Type | Price | Notes |
|---|---|---|
| Entry | $222.00 – $226.00 | Buy on reclaim of $220 |
| Stop Loss | $208.00 | Below monthly demand lower bound |
| Target 1 | $236.00 | Weekly supply lower bound |
| Target 2 | $250.00 | 50% retracement level |
Institutional Backing: Held by 2,445 funds.
MRX ($53.90) — Finance / Specialty Financial Services
Technical Setup: Marathon Petroleum (Ticker MRX in this dataset context) is showing strong momentum with a 5.7% gain and RVOL of 1.1. It is trading at a at_demand zone on the daily timeframe with a strength of 5.7. The stock is near its 52-week high (-8.1% away), suggesting a potential breakout. The demand zone ($51.00 – $52.85) provides a solid floor. While the ATR risk is high (165.6%), the aggressive price action and volume support a continuation trade if the $52.85 support holds.
Key Levels:
| Level Type | Price | Notes |
|---|---|---|
| Entry | $53.50 – $54.50 | Buy on strength above $53.90 |
| Stop Loss | $51.50 | Below daily demand upper bound |
| Target 1 | $57.80 | 1h Supply Zone Lower Bound |
| Target 2 | $60.00 | Psychological Resistance |
Institutional Backing: Held by 293 funds (Bucket B1, B2).
Honorable Mentions
- MGNX ($4.20): Strong 30m demand (Strength 6) with a massive 254% move from 52W low, but low RVOL (0.4) requires caution.
- IDXX ($560.73): Solid daily demand zone (Strength 5.7) with high institutional ownership, though supply is close at $590.
- CMBT ($14.81): Testing 30m demand with high strength (5.8), but down 3.6% today, suggesting a potential value trap without volume confirmation.
- CW ($733.88): Currently at supply, which is risky in a Cautious regime, though the monthly demand zone below is very strong (Strength 7.2).
- INSM ($103.86): Trading between zones with moderate institutional backing; requires a clear breakout above $110 to confirm continuation.
Strategy Summary
Today’s continuation setups are characterized by a heavy tilt toward the Medical and Defensive sectors, reflecting the Cautious market regime. The overall quality of signals is mixed; while the count is high (18), the bearish breadth suggests that many breakouts may lack follow-through.
Key Strategy: Focus on stocks with strong institutional backing (Bucket B1/B2) and clear, high-strength demand zones (Strength > 5.5). Avoid chasing breakouts that are already extended above supply zones. The best risk/reward profiles are found in LLY and CF, which offer clear support levels and institutional conviction. Traders should maintain tight stop losses, as the “Very Bearish” sentiment can quickly turn a technical setup into a failed breakout if the broader market dips.